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Abstract
The master circadian clock in mammals is located in the hypothalamic suprachiasmatic nuclei (SCN) and is synchronized by
several environmental stimuli, mainly the light-dark (LD) cycle. Light pulses in the late subjective night induce phase
advances in locomotor circadian rhythms and the expression of clock genes (such as Per1-2). The mechanism responsible for
light-induced phase advances involves the activation of guanylyl cyclase (GC), cGMP and its related protein kinase (PKG).
Pharmacological manipulation of cGMP by phosphodiesterase (PDE) inhibition (e.g., sildenafil) increases low-intensity light-
induced circadian responses, which could reflect the ability of the cGMP-dependent pathway to directly affect the photic
sensitivity of the master circadian clock within the SCN. Indeed, sildenafil is also able to increase the phase-shifting effect of
saturating (1200 lux) light pulses leading to phase advances of about 9 hours, as well as in C57 a mouse strain that shows
reduced phase advances. In addition, sildenafil was effective in both male and female hamsters, as well as after oral
administration. Other PDE inhibitors (such as vardenafil and tadalafil) also increased light-induced phase advances of
locomotor activity rhythms and accelerated reentrainment after a phase advance in the LD cycle. Pharmacological inhibition
of the main downstream target of cGMP, PKG, blocked light-induced expression of Per1. Our results indicate that the cGMP-
dependent pathway can directly modulate the light-induced expression of clock-genes within the SCN and the magnitude
of light-induced phase advances of overt rhythms, and provide promising tools to design treatments for human circadian
disruptions.
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Introduction
In mammals, the master circadian clock resides in the
hypothalamic suprachiasmatic nuclei (SCN), which is able to
adjust its parameters with a variety of environmental signals. The
light-dark (LD) cycle is the principal synchronizer of the biological
clock [1,2]; photic information reaches the SCN through the
retinohypothalamic tract (RHT) by means of a glutamatergic
signal, resulting in phase shifts of biological rhythms [3–6].
Exposure to light pulses (LPs) at night synchronizes the clock by
inducing phase delays during the early night and phase advances
during the late night [7,8]. In hamsters, responses to light during
the subjective night are mediated through a common signaling
pathway involving glutamate, Ca
2+, CaMKII and neuronal nitric
oxide synthase (nNOS), which couple photic stimulation to the
transcriptional activation of clock genes [9,10]. However, down-
stream of nitric oxide these pathways bifurcate [11]. During the
late night, the activation of a cGMP-dependent pathway —
including the activation of guanylyl cyclase (GC)— and the
activation of a cGMP dependent protein kinase (PKG) is involved
in phase advances [12–14]. Pharmacological manipulation of
cGMP by inhibition of its degradation pathway (i.e., by blocking
cGMP-phosphodiesterase (PDE) should therefore affect photic
entrainment and resynchronization.
cGMP-specific phosphodiesterase (PDE) inhibitors, which pre-
vent the hydrolysis of cGMP, allow the accumulation of cGMP in
the cells. Since several PDE families have been described [15], it is
important to consider the specificity of such inhibitors. In
particular, sildenafil directly inhibits the breakdown of cellular
cGMP by PDE5 [16] and thereby prolongs and enhances the
effects of NO/cGMP. In a previous study we demonstrated the
presence of PDE5 in the hamster SCN, and the ability of sildenafil
to both accelerate circadian resynchronization after an abrupt 6-h
advance of the LD cycle and to enhance advances of rhythmic
locomotor activity in response to a single LP during the subjective
night [17].
We hypothesized that the enhancement of phase advances by
PDE inhibitors could reflect the ability of the cGMP-dependent
pathway to directly affect the photic sensitivity of the master clock
within the SCN. We tested this hypothesis by assessing the ability
of sildenafil to enhance phase advances in response to saturating
levels of light in hamsters, as well as in a mouse strain that shows
reduced phase advances. We also tested the ability of pharmaco-
logical inhibition of the main downstream target of cGMP, PKG,
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utility of PDE inhibitors as pharmacological agents to accelerate
entrainment to advances of the LD cycle, we tested the ability of
PDE inhibitors other than sildenafil to enhance light induced
phase advances, as well as the ability of sildenafil to enhance light-
induced advances after intraperitoneal (ip.) injections in female
hamsters and oral administration in male hamsters.
The aim of the present work was to expand our previous
findings in the role of PDE in the circadian system [17]. In
particular we aimed to determine whether PDE inhibition affects
the photic sensitivity of the mammalian circadian clock. We used
additional approaches to this question, expanding the drugs to be
tested, using a different species (i.e. mouse), testing several light
intensities and also including male and female hamsters. All these
were combined with in situ hybridization and immunocytochem-
istry to assess the state of the molecular clock. Taken together, our
results suggest that the cGMP-dependent pathway can directly
modulate the light-induced expression of clock-genes within the
SCN and the magnitude of light-induced phase advances of its
master circadian oscillator.
Results
In a previous study we demonstrated that inhibition of PDE5 by
sildenafil increases a 50-lux light-induced phase advance but has
no effect when administered by itself in the absence of a LP, and
accelerates circadian reentrainment to a 6-h advance of the LD
cycle [17]. Our results suggest a possible role for PDEs in
modulating the sensitivity of the circadian system to photic
stimulation. Whereas low-intensity LPs have no significant effect
on the phase of circadian locomotor activity, LPs above a given
intensity threshold saturate the phase advance responses [18]. We
therefore tested the hypothesis that sildenafil could increase the
ceiling effect for light stimulation. We assessed the effect of
sildenafil or vehicle on sub-saturating (50 lux) saturating (300 lux)
and supra-saturating (1200 lux) light-induced phase advances
(Fig. 1). A two-way ANOVA yielded significant effects of treatment
and light intensity (p,0.0001), as well as for their interaction
(p=0.0036). This interaction was the result of the non-additive
effect of light intensity in control animals. A 50 lux LP 30 min
after vehicle administration induced a significantly lower phase
advance than a 300 lux and a 1200 lux pulse, but the advances did
not differ between 300 and 1200-lux treated animals (50 lux:
49611.44 min n=6; 300 lux: 204622 min n=6; 1200 lux:
234642.3 min n=8; p,0.0002, one-way ANOVA, followed by
Tukey’s test, 50 vs. 300 lux, p,0.0005; 300 vs. 1200 lux, n.s.; 50
vs. 1200 lux, p,0.0005). In contrast, sildenafil increased the phase
advance induced by a 1200-lux pulse when compared to both a 50-
lux and a 300-lux pulse (50 lux: 144.8614.68 min n=6; 300 lux:
336667 min n=6; 1200 lux: 561657.7 min n=8, p,0.0001,
one-way ANOVA, Tukey’s test: 50 vs. 300 lux, p,0.005; 300 vs.
1200 lux, p,0.005; for 50 vs. 1200 lux, p,0.0005). In addition,
sildenafil reduced the number of transient days after the 1200 lux
and the 300 lux LP until a new stable phase was achieved
(2.5760.42 days vs. 5.3360.42 days in control animals, p,0.001
and 5.6760.49 days in sildenafil-treated vs. 7.1660.30 days in
control animals, p=0.027 respectively, Student’s t-test) (data not
shown).
In order to discard direct retinal effects of this PDE inhibitor, we
performed electroretinographic recordings following ip. adminis-
tration of 3.5 mg/kg sildenafil. No significant changes were found
for amplitude nor latency of the a (amplitude: controls 3665 mV
vs sildenafil 4164 mV; latency: controls 2860.7 msec vs sildenafil
2961.2 msec) nor the b wave of the ERG (amplitude: controls
9268 mV vs sildenafil 10267 mV; latency: controls 5362 msec vs
sildenafil 5762 msec) after sildenafil administration (Figure S1).
Taken together, our results demonstrate that sildenafil (i.e., PDE
inhibition) affects the light-input threshold for circadian phase
shifts. Furthermore, the intensity-response curve in sildenafil-
treated animals indicates a linear relationship between light
intensity and phase advances, with no plateau achieved with
stimulations of up to 1200 lux. In other words, PDE inhibition has
the ability to enhance light-induced phase advances beyond the
saturation point for vehicle-treated animals.
Sildenafil administration also accelerated the reentrainment rate
of body temperature in our jet-lag simulation model (Fig. 2). After
a 6-h advance of the LD cycle, animals injected with sildenafil
(3.5 mg/kg) reentrained their body temperature rhythm signifi-
cantly faster (660.41 days) than those injected with vehicle
(860.41 days, p,0.05 Student’s t-test) (n=6 per group).
To assess the potential use of orally administered PDE inhibitors
to enhance circadian phase advances, male hamsters received
3.5 mg/kg sildenafil through a gavage syringe 30 min before
a 300 lux LP at CT18. Oral sildenafil significantly increased the
phase-advancing effect of the stimulus (sildenafil 357.3651.8 min
vs. vehicle 12369.6 min, p,0.025, Student’s t-test; n=6 per
group) (Data not shown).
Figure 1. Sildenafil administration increases light-induced
phase advances. In control animals a 300 lux light pulse induced
a significantly higher phase advance than a 50 lux light pulse, while
there was no difference between the 1200 lux and 300 lux groups. In
contrast, the analysis of sildenafil treatment shows significant
differences within the three groups (see text for details). All data
represented as mean (6 SD). Representative actograms (top) are
presented for vehicle or drug treatment; time of injection and LP are
indicated by a star, a grey bar shows estimated onset.
doi:10.1371/journal.pone.0037121.g001
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generalized to another mammalian species we also studied the
photic response in mice, by assessing the effect of light pulses as
a proof of concept that sildenafil can affect circadian entrainment
in this rodent. The C57-BL/6J mouse strain is a particularly
interesting model because it exhibits relatively small phase
advances in response to a LP during the late subjective night
[19]. As shown in Fig. 3, ip administration of sildenafil induced a 3-
fold potentiation of this strain-specific phase-advancing ability:
while control mice receiving vehicle 30 min before a 300-lux LP
starting at ZT19 showed a phase advance of 3064.5 min, drug-
treated animals (3.5 mg/kg) showed a 88.765.06 min phase shift
(p,0.0025, Student’s t-test; n=8 per group).
Inhibition of PDE activity after saturating LPs in hamsters at
CT 18 and at CT19 in mice (a time when, according to the phase
response curve, is not the zone for maximum light-induced phase
advances) led to phase shifts that are not encountered under
normal conditions in either species. Taken together, these results
suggest that the inhibition of cGMP degradation may lead to
parameter changes in the master circadian oscillator itself. Phase
shifts in mammals are correlated with (and possibly mediated by)
the photic-induction of Per1, a central gene in the molecular clock
machinery. Accordingly, LPs at CT18 induce the acute expression
of Per1 in the SCN (Fig. 4). In order to test whether cGMP levels,
and its downstream mechanisms, could directly modulate the
increased expression of this core molecular clock component, we
administered KT-5823 (i.c.v. 200 mM, 1,5 ml), a PKG inhibitor,
which significantly blocked light-induced Per1 expression. One-
way ANOVA (p=0.023, n=6 per group) followed by Tukey’s test
yielded differences between vehicle-treated animals under light or
dark conditions (p=0.0032) without affecting the normal distri-
bution of Per1 within the SCN. Indeed, an analysis of the signal
intensity in the dorsal region vs. the ventral region showeds no
difference between the vehicle- and KT-5823-treated hamsters
(data not shown). Moreover, PKG inhibition significantly blocked
Per1 induction (light-treated vs. light+KT-5823-treated animals,
p=0.0235) while KT-5823 alone had no effect on Per 1 induction
(Dark vs KT-5823 alone p=0.2121).
To better understand how PDE inhibition acts on the circadian
clock we analyzed the expression of PER1 protein in the SCN at
a short time after the LP. Sildenafil administration increased the
number of PER1-ir cells as early as 60 minutes after the LP (Fig. 5).
Two-way ANOVA indicated a significant effect of treatment
(p,0.0001) as well as of time (p,0.0001), with interaction
between these two factors (p=0.0011). There were no significant
differences between vehicle- and sildenafil-treated animals 5 min
after the light pulse (10064.9 min vs. 11063.9 min, respectively,
p=0.1294, Tukey’s test); however, there was significant increase
in PER1-ir cells 60 min post-stimulation (control: 314.468.1 vs.
Figure 2. PDE inhibition accelerates circadian reentrainment of
body temperature in a jetlag simulation model. Male hamsters
injected with sildenafil entrained their body temperature rhythm to a 6-
hr advance of the LD cycle significantly faster than those injected with
vehicle. N=6 per group. *p,0.05, Student’s t-test. Data represented as
mean (6SD). Representative actograms (top) shows body temperature
values between 36 and 39uC. Dark phases are indicated by gray
shading.
doi:10.1371/journal.pone.0037121.g002
Figure 3. PDE inhibition increases 300 lux light-induced phase
advance in mice. 300 lux light pulse (10 min.) at CT19 after sildenafil
injection induced a phase advance that was significantly higher than
the one for vehicle-treated animals. **p,0,0025 Student’s t-test (n=8
per group). Data represented as mean (6SD) Representative actograms
(top) show vehicle or drug treatment, time of injection and LP are
indicated by a star.
doi:10.1371/journal.pone.0037121.g003
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group). An analysis of the percentage of PER1-ir cells within the
dorsal and ventral regions of the SCN indicated no effect on the
distribution of PER1 in these regions when comparing control-
and sildenafil-treated hamsters (data not shown).
We also studied the effect of several PDE inhibitors on circadian
photic responses to subsaturating-LP. The ip. administration of
PDE inhibitors sildenafil (3.5 mg/kg), vardenafil (0.7 mg/kg) and
tadalafil (1.4 mg/kg) 30 min before a 10-min 50-lux LP at CT18
significantly increased light-induced phase advances as compared
to control animals receiving vehicle solution (Fig. 6A, B). The
increase in phase shifts was of 290% (sildenafil), 235% (vardenafil)
and 252% (Tadalafil) (ANOVA, p=0.001, followed by Tukey’s
test of each drug vs. the vehicle, p,0.0025; n=6 per group).
We also studied the effect of sildenafil, vardenafil and tadalafil
on circadian reentrainment after a 6-h advance of the LD cycle
(Fig. 6C,D). By recording the time until the start of locomotor
activity coincides with the new time for dark onset, we found that
control hamsters receiving vehicle synchronized to the new phase
in 11.861.97 days. Reentrainment time was reduced by half by
the ip administration of sildenafil (4.460.86 days), vardenafil
(5.860.91 days) or tadalafil (5.860.79 days) (ANOVA, p=0.0011
followed by Tukey’s test for each drug vs. the vehicle, p,0.0025,
p,0.05, p,0.05 respectively, n=6 per group).
In addition, we tested whether there are sexual differences in the
ability of PDE inhibitors to increase circadian phase advances.
Male or female hamsters receiving an ip. injection of sildenafil
30 min before a 300 lux LP at CT18 exhibited a circadian phase
advance of 336667 min and 349673 min, respectively, while
vehicle-treated animals showed a 204622 min (males) or
200637 min (females) phase advance (data not shown). Two-
way ANOVA revealed a main effect of treatment (P=0.0012) but
not of sex (P=0.865; n=6 per group), suggesting that sildenafil
has no sex-specific effect in the potentiation of circadian
photoresponsiveness.
Discussion
The NO-cGMP-PKG pathway is known to be involved in
circadian synchronization, more specifically in phase advances of
the circadian system in response to light [10,14,17,20–23]. cGMP
levels increase significantly during the late night after a phase-
advancing LP, but do not change during early night photic
stimulation, supporting its role in mediating phase advances but
not phase delays [12,24]. In addition, cGMP levels in the hamster
SCN exhibit a circadian rhythm with a maximum during the day.
This rhythm seems to be related to degradation by a specific PDE,
and not to synthesis mediated by GC activity [24]. Thus, the
regulation of PDE activity is at the core of the mechanisms
underlying the phase-specific effects of light on the circadian
pacemaker. In the present work we studied the role of cGMP in
the photic response of the circadian system by specific inhibition of
PDE5 by sildenafil, tadalafil or vardenafil, three drugs commonly
used for treatment of erectile dysfunction [25].
Importantly, sildenafil increased the response not only to
a 300 lux LP, but also to a 1200 lux LP (well above saturating
threshold). In the latter case, animals exhibited a two-fold increase
in phase advances and a significant reduction in the transient days
to the new phase. Moreover, the induced increase in phase shifts
after 1200 lux pulses (which resulted in ,9 h phase advances)
suggests that sildenafil (and related compounds) increases the
photic sensitivity of the circadian clock. Indeed, PDE activity in
the SCN might act as an endogenous attenuating factor for light-
Figure 4. The inhibition of PKG blocks light-induced Per1
expression in the SCN. Administration of KT-5823 (icv, 200 mM,
1,5 ml), a PKG inhibitor, significantly blocked light-induced Per1
expression in the hamster SCN (p=0.023 compared with light, ANOVA
followed by Tukey’s test), while KT-5823 alone had no effect on Per1
induction. Data represented as mean of relative OD (ratio OD SCN/OD
surrounding hypothalamus) 6SD.
doi:10.1371/journal.pone.0037121.g004
Figure 5. Administration of Sildenafil (3.5 mg/kg) 30 min.
before a 300 lux light pulse increase the light-induced phase
advance. Animals were sacrificed 5 or 60 minutes after LP. Sildenafil
administration increased the number of PER1-ir cells in the SCN. Two-
way ANOVA indicated a significant effect of treatment (p,0.0001) and
time (p,0.0001), with interaction between these two factors
(p=0.0011) due to the basal expression at 5 min group. A t-Test
demonstrates no differences in 5 min group between vehicle an
sildenafil (10064.918 vs. 11063.96. respectably. p=0.1294) but shows
an increase in the PER1-ir cells at 60 min. (314.468.103 vs. 401.1617.99
respectably. P=0.0009) (n=8 per group). Representative coronal
sections from hamsters containing the medio-caudal portion of the
SCN 5 and 60 min after light pulse with previous injection of sildenafil
or vehicle (3 V: third ventricle; OC: optic chiasm; Scale bars: 100 mm).
doi:10.1371/journal.pone.0037121.g005
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release the circadian pacemaker from this attenuating effect.
Per1 is an essential player in the molecular feedback loop that
generates circadian rhythms, and is critically involved in resetting
the endogenous clock to light signals. Per1 mRNA and protein
levels increase after a LP at late night [26–28]. Here we show that
PKG inhibition by KT-5823 blocks the light-induced Per1
expression in the hamster SCN. In addition, our results show that
increases in cGMP levels, by means of sildenafil administration,
induces a higher number – as compared to controls – of PER1-ir
cells in the SCN 60 min after a LP. This increase is concomitant
with an enhancement of behavioral phase advances and is
consistent with previous reports showing that Per1 levels in the
SCN increase proportionally with light intensity and in parallel
with the magnitude of behavioral phase shifts [29]. Our data also
support the notion that the phase resetting of the circadian clock
likely involves not only the rapid Per1 activation at subcellular
level, but also the recruitment of neuronal oscillators in the SCN
[30]. In this way, photic stimulation of the cGMP pathway may
not only lead to changes at single-cell level but also in changes in
the SCN neuronal network properties.
There are several indications about a possible role of PDE
inhibitors for the treatment of central nervous system diseases (i.e.,
[31–33]. In the present study we show that the use of any of three
different PDE inhibitors induced a more than two-fold increase in
the low-intensity light-induced phase advance, and clearly
accelerated behavioral re-entrainment after a 6-h advance in the
LD cycle. All three drugs have similar efficacy in both low-
intensity light- induced phase advances and re-entrainment after
a 6-h advance in the LD cycle. However, although these drugs are
clearly specific for PDE5 inhibition, their effect on other isoforms
cannot be discarded; for example, tadalafil has been reported as
a PDE11 inhibitor but with an IC50 seven times higher than for
PDE5 (10 nM and 73 nM respectively) [34]. Several PDE
isoforms, in addition to PDE5, are expressed in the SCN
according to PCR analysis (Agostino et al., unpublished), and
could represent additional targets for pharmacological manipula-
tion of circadian responses to light.
There is a close relationship between the body temperature
rhythm and the circadian rhythm of locomotor activity, which
suggests a common regulation for the thermoregulatory system
and the general sleep pattern [35,36]. Locomotor activity rhythm
has an important influence on core body temperature mainly
during the day (when both temperature and activity are low) than
during the night [37]. Indeed, resynchronization of body
temperature cycles after jet-lag is essential for the restoration of
body synchrony and an adequate sleep-wake pattern [38,39]. In
addition, body temperature was recently proposed to be a key
component for the internal synchronization of peripheral clocks
[40]. Here we show that sildenafil administration also accelerated
resynchronization of the body temperature circadian rhythm after
a 6-h phase change in the LD cycle. The observed shifts in the
body temperature rhythm could in part reflect the effect of
locomotor activity as a heat-inducing factor, which can mask the
true circadian phase of the temperature rhythm [41,42]. It is
important to note, however, that the effect of PDE inhibition on
the reentrainment of the temperature rhythm was observed in
hamsters without access to running wheels, in which the effects of
heat-induced activity should be less prominent [43,44]. Our data
supports the idea that core body temperature rhythms and
locomotor activity rhythms synchronize with different speed to
a 6 h advance of the LD cycle. This difference in the speed of
reentrainment among different variables was reported previously
[45,46]. The systems that control locomotor activity and
temperature rhythms may process the SCN signals in a different
Figure 6. PDE inhibition by different compounds increases low-intensity light-induced phase advances and accelerates circadian
reentrainment. A) and B) 50 lux light pulses at CT18 induced a phase advance that was significantly increased by sildenafil, vardenafil or taladafil as
compared to vehicle-treated animals. Representative actograms in panel A show vehicle or drug treated-animals; time of injection and LP are
indicated by a star and the grey bar shows locomotor activity onsets. Panel B shows the average results, ANOVA-p,0.001- followed by Tukey’s Test
**p,0,0025. C) Representative actograms showing reentrainment to a 6 h phase advance of the LD cycle for vehicle or drug-treated animals; dark
phases are indicated by gray shading and a black bar depicts the transient days until the new phase. Grey horizontal bars indicate computer
malfunction. D) Animals injected with PDEs inhibitors entrained significantly faster to a 6-hr advance of the LD cycle than those injected with vehicle.
N=6 per group. ANOVA-P=0.0011- followed by Tukey’s Test *P,0.05, **p,0.0025. All data represented as mean (6 SD).
doi:10.1371/journal.pone.0037121.g006
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output rhythms [47,48]
In recent years the use of sildenafil has become the therapy of
choice for the treatment of erectile dysfunction. Its additional
applications in human health, including its use as a chronobiotic
drug, remain to be determined, although there have been some
indications regarding its efficacy in some sleep-related disorders
such as obstructive sleep apnea [49,50]. In order to further
validate the use of sildenafil as a chronobiotic we extended our
results to a mouse model. Remarkably, sildenafil was able to
enhance light-induced phase advances during the late subjective
night in a mouse strain in which this response is very low.
In addition, the use of sildenafil for purposes other than
treatment of erectile dysfunction, including in urology and
cardiovascular medicine as well as in respiratory dysfunctions
has been recommended for males and females (Konstantinos and
Petros, 2009). Our results indicate this may be the case for its use
as a chronobiotic as well, since it was equally effective in
enhancing light-induced phase advances in females as it was in
males. Finally, oral administration of sildenafil also proved to be
effective in the potentiation of circadian photoresponsiveness,
underscoring its potential as an easily deliverable chronobiotic.
Although it is possible that sildenafil might increase retinal
sensitivity to light [51–54], we have performed experiments that
indicate that ip. administration of sildenafil does not change
electroretinographic recordings, which, together with the fact that
peripheral application of sildenafil results in significant changes in
SCN cGMP levels [17], suggests that the results reported herein
represent a change at the SCN level. Although other studies have
reported that either in vitro or prolongues high doses of sildenafil
changes the amplitude of both a and b ERG waveforms [55,56],
the current dose employed in hamsters did not affect retinal
electrophysiology.
cGMP effects on photic shifting of the circadian system are
mediated through PKG activation [24,57], since inhibition of this
kinase blocks the light-induced phase advance. Moreover, targeted
disruption of PKG affects photic entrainment and Per1-2
expression in the SCN [58]. It is not known how this activation
of PKG acts in the circadian system, although some potential
substrates have been postulated (e.g., DARPP-32 [59] leading to
the activation of clock genes.
Our studies indicate that the cGMP-related signal transduction
pathway is a potential pharmacological target for circadian
disruptions. In particular, jet-lag as well as shift-work schedules
increase the risk of accidents and health problems, including
decreased alertness, reduced psychomotor coordination, cognitive
deficits, insomnia, reduced performance, loss of appetite, gastro-
intestinal disease, and even accelerated malignant growth [60–62].
Interestingly, several lines of evidence suggest that the response to
phase-advancing —as compared to phase-delaying— schedules
appears to be more disadvantageous for health and quality of life
both in humans and experimental animals [63–66]. This outcome
may result from an alteration of the internal phase coordination, as
well as in the lack of synchrony between the body clock and the
environment. Our results indicate that PDE inhibition in
conjunction with light administration might be a useful therapy
to induce the rapid adaptation of the circadian system to temporal
environmental challenges such as rotating shift-work and jetlag.
Genetic sleep disorders may represent another target for PDE-
inhibition therapy. For instance, in advanced sleep-phase
syndrome, patients report daytime somnolence and difficulties to
sleep at night [67,68]. This syndrome is associated with a specific
mutation in the human clock genes Per2 and CKI delta [69,70],
and current treatments include phototherapy and the use of
chronobiotics such as melatonin (or its analogs ramelteon and
tasimelteon) or armodafinil [71–73]. Our results with experimental
animals suggest that PDE inhibition might be added to the list of
potentially useful treatments for this and other circadian disorders.
Materials and Methods
Ethics Statement
All animal procedures were performed in strict accordance with
National Institutes of Health rules for animal care and mainte-
nance. The study protocols were approved by the Universidad
Nacional de Quilmes Institutional Animal Care Committee.
Animals
Male and female adult (3–4 months old) Syrian hamsters
(Mesocricetus auratus) were raised in our colony and maintained in
a 14:10-h LD cycle, with food (Purina chow) and water ad libitum
and room temperature set at 2062uC. Adult (2 months old) C57-
BL/6J male mice (Mus musculus) were raised in our colony under
a 12:12-h LD cycle, with food and water ad libitum and room
temperature set at 2062uC.
Locomotor activity Rhythms
Animals were transferred to individual cages equipped with
a running wheel (18-cm diameter) and with light intensity
averaging 300 lux at cage level. Locomotor activity circadian
rhythm was assessed through wheel-running recording (Archron,
Argentina). Wheel revolutions were monitored by magnetic
microswitches and recorded every 5 min. Time is expressed as
Zeitgeber time (ZT), with ZT12 defined as the time of lights off.
Animals were initially maintained under a LD cycle for at least 10
days. For reentrainment studies, hamsters were subjected to an
abrupt 6-h advance in the phase of the LD cycle, achieved by
advancing the time of lights-off and lengthening of the dark phase.
On the day of the shift, intraperitoneal (ip.) injection of sildenafil,
tadalafil, vardenafil or vehicle was given at ZT18 of the previous
cycle. Time for reentrainment to the new LD cycle was defined as
the time —expressed in days— it took for each animal to achieve
a stable new activity onset in the new cycle. Resynchronization
was considered fully accomplished when activity onset took place
at the new time of lights off 615 minutes. Daily onsets of activity
were determined following published criteria [47]. Briefly, activity
onset was defined as the first 5-min bin that contained at least 80
wheel revolutions, followed by another bin of at least another 80
wheel revolutions within 40 min.
For LP experiments, animals (hamsters or mice) were trans-
ferred to individual cages equipped with a running wheel and
placed in constant darkness (DD) conditions. For light-induced
phase advances of circadian wheel running activity, animals were
removed from their cage in DD and exposed to a 10-min white LP
of 50, 300 or 1200 lux at circadian time (CT) 18 for hamsters or
a 300 lux LP at CT 19 for mice (with CT 12 defined as the onset
of wheel running activity in DD). Animals were returned to DD
after light exposure. In a previous work we demonstrate that
sildenafil administration without light stimulation has no effect in
the phase or the period of the animals (Agostino 2007). Phase
advances were calculated by fitting a line through activity onsets
during the 5 days prior to stimulation and then calculated
circadian phase starting on the second day after a stable onset was
achieved, using the data of the following 5–7 days to extrapolate to
the day of the light pulse. This stable condition was defined as
activity onset between consecutive days differing by not more than
15 circadian minutes Phase shifts were estimated by three
observers masked to the experimental procedure. Animals re-
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light stimulation and returned into DD. The transient period was
defined as the number of days it took for each animal to achieve
a new stable phase.
Drug administration
The effect of 3.5 mg/kg sildenafil, 0.7 mg/kg tadalafil and
1.4 mg/kg vardenafil (extracted from commercial preparations,
diluted in 50% DMSO/saline solution) was tested in comparison
to vehicle administration [74]. In each experiment, 6 previously
untreated hamsters were used for each dosage group or vehicle
control. 50% DMSO/saline solution was used as a vehicle.
For the oral administration experiment, 3.5 mg/kg of sildenafil
powder (suspended in water) or vehicle were given to hamsters
with the assistance of a gavage syringe 30 min before a 300-lux LP
at CT18.
Electroretinography
Electroretinographic activity was assessed in dark-adapted
rodents as previously described [75,76]. Briefly, after 6 h of dark
adaptation, male hamsters were injected with 3.5 mg/kg of
sildenadil ip, and 30 minutes later were anesthetized with an
intraperitoneal injection of ketamine hydrochloride and xylazine
hydrochloride under dim red illumination. Phenylephrine hydro-
chloride (2.5%) and 1% tropicamide (Alcon Laboratories,
Argentina) were used to dilate the pupils, and the cornea was
intermittently irrigated with balanced salt solution (Alcon Labo-
ratories, Argentina) to maintain the baseline recording and to
prevent exposure keratopathy. All recordings were completed
within 20 min of the induction of anesthesia. Electroretinograms
(ERGs) were recorded from both eyes simultaneously and ten
responses to flashes of unattenuated white light (5 ms, 0.2 Hz)
from a photic stimulator (light-emitting diodes) set at maximum
brightness (9 cd s/m2 without a filter) by a full-field Gandzfeld,
were amplified, filtered (1.5-Hz low-pass filter, 1000 high-pass
filter, notch activated) and averaged (Akonic BIO-PC, Akonic,
Argentina). The a-wave was measured as the difference in
amplitude between the recording at onset and the trough of the
negative deflection and the b-wave amplitude was measured from
the trough of the a-wave to the peak of the b-wave. Electrophys-
iological responses were averaged for each run. Runs were
repeated 3 times with 5 min-intervals, and the mean of these 3
runs was used for subsequent analysis. We compared the mean
peak latencies and peak-to-peak amplitudes of the responses from
each group of hamsters.
Body temperature rhythms
To continuously record the body temperature an I-button
device (DS1921h-F50, Thermochron, Sunny vale, Ca), set to start
7 days post-surgery, was implanted in the peritoneal cavity of
hamsters [77,78]under 75 mg/kg ketamine and 10 mg/kg
xylazine anesthesia cocktail by ip. route. Hamsters were placed
in individual cages without running wheels, and body temperature
recordings taken every 20 min. Body temperature was filtered to
analyze only between 36 and 39uC. Daily onset was defined as the
first 5 min-bin with recordings of least 37uC, followed by 8 bins of
at least another recording of 37uC within 60 min. Animals were
initially maintained under a 14:10-h LD cycle (lights on at
1900 hours) for at least 10 days. Then, hamsters were subjected to
an abrupt 6-h advance in the phase of the LD cycle as described
above. On the day of the shift, intraperitoneal (ip.) injection of
sildenafil or vehicle was given at ZT18 of the previous cycle. Time
for reentrainment to the new LD cycle was defined as the number
of days it took for each animal to achieve a stable new onset of the
temperature rhythm. Resynchronization was considered fully
accomplished when body temperature had a new stable phase
with a 24 h period.
PER1 immunohistochemistry
Free-running male hamsters were divided into groups receiving
ip. injection of sildenafil or vehicle solution (n=8 per group)
40 min before a LP (300 lux, 10 min) at circadian time 18 (CT
18). Hamsters were anesthetized with ketamine/xylazine and
perfused with 0.1 M phosphate buffer followed by 4% para-
formaldehyde in 0.1 M phosphate buffer 5and 60 minutes post
LP, and their brains were removed and postfixed for 5 additional
hours. The tissue was cryoprotected in 30% sucrose in phosphate
buffer saline (PBS) solution and cut into 30 mm coronal sections
with a freezing microtome to perform a standard immunohisto-
chemical procedure. Briefly, sections were incubated for 72 h in
PBS with 0.4% Triton (PBST) at 4uC with rabbit anti-PER1
antibody (Affinity BioReagents, Rockford, IL, USA) diluted 1:200,
washed in PBST, incubated with biotinylated universal secondary
antibody (Vector Labs, Burlingame, CA, USA) diluted 1:200, and
finally incubated with the avidin-biotin complex (Vectastain Elite
ABC kit, Vector Labs). The sections were then reacted with
Vector VIP reagent (Vector Labs) to visualize the peroxidase
reaction, and mounted on microscope slides. The number of
PER1 immunoreactive SCN cells (PER1-ir cells) was determined
manually using the cell counter plugin of the ImageJ program
(NIH). The percentage of ir-cells in the dorsal and ventral regions
of the SCN was measured as previously described [21]
In-situ hybridization of Per1
Male Hamsters were sacrificed by decapitation 1 h post LP,
brains were rapidly removed and frozen in 2-methylbutane cooled
to 230uC with dry ice, and 16-mm thick coronal sections through
the SCN were cut on a cryostat and mounted on slides coated with
Vectabond (Vector Labs). Sections were processed for in situ
hybridization as previously described [79]. Briefly, sections were
fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, treated
with 0.1 M triethanolamine hydrochloride (pH 8.0) with 0.25%
aceticanhydride, rinsed in 26 sodium citrate/sodium chloride
(SSC), dehydrated with alcohol and delipidated with chloroform.
Sections were incubated in pre-hybridization buffer and hybrid-
ized overnight at 55uC in hybridization buffer containing 10%
dextran sulfate, 50% formamide, 0.3 M NaCl, 10 mM Tris,
1 mM EDTA, 16 Denhardt’s solution, 200 mM dithiothreitol
and 0.5 mg/ml yeast tRNA containing4610
7 c.p.m./ml of the
35S-labeled cRNA probe. The sections were then washed in 50%
formamide/50% 26 SSC several times, incubated in RNase A
(20 mg/ml) and washed again in formamide/26SSC. Slides were
dehydrated in alcohol, dried and exposed to Hyperfilm-bmax
(Amersham, Arlington Heights, IL). All solutions before RNase
treatment were prepared with diethyl pyrocarbonate-treated
RNase-free water.
The optical density (OD) of the autoradiographic hybridization
signal was measured using a Zeiss (Kontron) Image Processing
System. The average OD for each SCN was derived from at least
two sections through the nucleus, each expressed as a relative OD
(ratio OD SCN/OD surrounding hypothalamus).
Supporting Information
Figure S1 Electroretinogram of sildenafil treated ham-
sters. Sildenafil administration (3.5 mg/kg) does not affect retinal
sensitivity to light. Animals were treated with sildenafil or vehicle
30 minutes before ERG, no significant changes were found for
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